OGEN vs OGN · rev $37.7K vs P/E 3.4, rev $6.40B
Oragenics Inc (OGEN) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
OGEN currently screens at market cap $2.7M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the OGEN and OGN stock pages for the full models.
Not investment advice.